(Press-News.org) An additional 18 months of dual antiplatelet therapy among patients who received a bare metal coronary stent did not result in significant differences in rates of stent thrombosis (formation of a blood clot), major adverse cardiac and cerebrovascular events, or moderate or severe bleeding, compared to patients who received placebo, according to a study in the March 17 issue of JAMA. The authors note that limitations in sample size may make definitive conclusions regarding these findings difficult.
Current clinical practice guidelines recommend a minimum of only 1 month of dual antiplatelet therapy (DAPT) after bare metal stent (BMS) placement following elective percutaneous coronary intervention (PCI; a procedure used to open narrowed coronary arteries, such as stent placement), compared with 6 to 12 months for drug-eluting stents (DES). Although randomized trial results showed a reduction in stent thrombosis and nonstent-related heart attack with thienopyridine therapy (a class of antiplatelet agents) beyond 12 months after DES placement, few trials have assessed optimal duration of DAPT after BMS, according to background information in the article.
Dean J. Kereiakes, M.D., of the Christ Hospital Heart and Vascular Center, Cincinnati, and Laura Mauri, M.D., M.Sc., of the Harvard Clinical Research Institute and Brigham and Women's Hospital, Boston, and colleagues randomly assigned 11,648 patients who received a bare metal stent (n = 1,687;) or drug eluting stent (n = 9,961), were treated with aspirin and who completed 12 months of DAPT without bleeding or ischemic events to continued thienopyridine or placebo at months 12 through 30.
Among the patients treated with BMS who were randomized to continued thienopyridine vs placebo, rates of stent thrombosis were 0.5 percent vs 1.11 percent; rates of major adverse cardiac and cerebrovascular events (MACCE; composite of death, heart attack, or stroke) were 4.04 percent vs 4.69 percent; and rates of moderate/severe bleeding were 2.03 percent vs 0.90 percent, respectively.
Among all 11,648 randomized patients (both BMS and DES), stent thrombosis rates were 0.41 percent vs 1.32 percent; rates of MACCE were 4.29 percent vs 5.74 percent, and rates of moderate/severe bleeding were 2.45 percent vs 1.47 percent.
The results comparing continued thienopyridine vs placebo in the cohort treated with DES were previously reported and demonstrated significant reductions in stent thrombosis and MACCE.
The authors write that fewer patients treated with BMS were enrolled and randomized because of the prevailing use of DES in clinical practice. "The BMS subset may have been underpowered to identify such differences [in adverse events], and further trials are suggested."
INFORMATION:
(doi:10.1001/jama.2015.1671; Available pre-embargo to the media at http://media.jamanetwork.com)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
An examination of the reporting of noninferiority clinical trials raises questions about the adequacy of their registration and results reporting within publicly accessible trial registries, according to a study in the March 17 issue of JAMA.
Noninferiority clinical trials are designed to determine whether an intervention is not inferior to a comparator by more than a prespecified difference (known as the noninferiority margin). Selection of an appropriate margin is fundamental to noninferiority trial validity, yet a point of frequent ambiguity. Given the increasing ...
WASHINGTON, D.C., March 17, 2015 - Winter storms dumped records amounts of snow on the East Coast and other regions of the country this February, leaving treacherous, icy sidewalks and roads in their wake. Now researchers from Canada are developing new methods to mass-produce a material that may help pedestrians get a better grip on slippery surfaces after such storms.
The material, which is made up of glass fibers embedded in a compliant rubber, could one day be used in the soles of slip-resistant winter boots. The researchers describe the manufacturing process in a ...
For every parent who ever wondered what the heck their teens were thinking when they posted risky information or pictures on social media, a team of Penn State researchers suggests that they were not really thinking at all, or at least were not thinking like most adults do.
In a study, the researchers report that the way teens learn how to manage privacy risk online is much different than how adults approach privacy management. While most adults think first and then ask questions, teens tend to take the risk and then seek help, said Haiyan Jia, post-doctoral scholar in ...
Large-scale climate patterns that affect the Pacific Ocean indicate that waters off the West Coast have shifted toward warmer, less productive conditions that may affect marine species from seabirds to salmon, according to the 2015 State of the California Current Report delivered to the Pacific Fishery Management Council.
The report by NOAA Fisheries' Northwest Fisheries Science Center and Southwest Fisheries Science Center assesses productivity in the California Current from Washington south to California. The report examines environmental, biological and socio-economic ...
AUSTIN, Texas - A new method of testing the most common cause of life-threatening infection in people with cystic fibrosis could improve efforts to study and combat the illness.
The bacterium Pseudomonas aeruginosa is a leading contributor to hospitalizations, serious illness and early death for people with cystic fibrosis (CF). Scientists at The University of Texas at Austin have found a way to re-create conditions specific to the environment in which the bacterium spreads in the lungs of a person with CF, allowing them to identify several genes that appear to be necessary ...
The New Zealand Meteorological Service issued a Storm Warning for the Chatham Islands today as NASA's RapidScat instrument found that winds in one quadrant of Ex-Tropical Cyclone Pam is still generating tropical-storm-force winds east of its center.
The International Space Station's RapidScat instrument captured data on Ex-Tropical Cyclone Pam's winds on March 16 from 08:30 to 11:36 UTC. RapidScat revealed sustained winds over 30 meters per second (108 kph/67 mph) were still occurring southeast of the center.
The forecast calls for southwesterly winds to 50 knots (57 ...
INDIANAPOLIS - An Indiana University cancer researcher and her colleagues have identified genetic markers that may help determine who benefits from regular use of aspirin and other nonsteroidal anti-inflammatory drugs for lowering one's risk of developing colorectal cancer.
Previous studies have shown that regular use of aspirin and NSAIDs lower one's risk of colorectal cancer, but their use is not recommended as a way to prevent the disease because of uncertainty about the risks and benefits. Thus, the researchers set out to examine the interrelationship between genetic ...
New research published with the support of the FP7 large-scale bioinformatics project Building the European Biodiversity Observation Network (EU BON) and the Alien Challenge COST action reveals the importance of open data in the study and control of invasive alien species. The study was published online in open access in the journal Management of Biological Invasions.
Invasive alien species cause a wide variety of problems, including issues related to conservation; to human and animal health; to agriculture and to fisheries management. But how can science be useful to ...
Cramping abdominal pains, diarrhea, bloody stools--these are common symptoms of chronic inflammatory bowel disease. Every year, up to 1470 children and adolescents in Germany develop the disease. But chronic inflammatory bowel disease is mostly diagnosed too late in these patients, as Stephan Buderus, Dietmar Scholz, and colleagues show in an original article in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2015; 112: 121-7). The average delay between initial symptoms and diagnosis is four to six months. In most cases, the inflammation ...
DETROIT - New animal studies at Henry Ford Hospital found that sildenafil, a drug commonly used to treat erectile dysfunction, may be effective in relieving painful and potentially life-threatening nerve damage in men with long-term diabetes.
The research targeted diabetic peripheral neuropathy, the most common complication of diabetes, affecting as many as 70 percent of patients.
The study was recently published online in PLOS ONE.
Lei Wang, M.D., the Henry Ford neuroscientist who led the research, said that although numerous drugs have been shown to be effective in ...
